Radboud Repository

      View Item 
      •   Radboud Repository
      • Collections Radboud University
      • Datasets
      • View Item
      •   Radboud Repository
      • Collections Radboud University
      • Datasets
      • View Item
      JavaScript is disabled for your browser. Some features of this site may not work without it.
      BrowseAll of RepositoryCollectionsDepartmentsDate IssuedAuthorsTitlesDocument typeThis CollectionDepartmentsDate IssuedAuthorsTitlesDocument type
      StatisticsView Item Statistics

      Data belonging to 'Smoking intensity and bladder cancer aggressiveness at diagnosis'

      Find Full text
      Creators
      Kiemeney, L.A.L.M.
      Date of Archiving
      2018
      Archive
      DANS EASY
      DOI
      https://doi.org/10.17026/dans-2a6-ate2
      Related publications
      Smoking intensity and bladder cancer aggressiveness at diagnosis  
      Publication type
      Dataset
      Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/183272   https://hdl.handle.net/2066/183272
      Display more detailsDisplay less details
      Organization
      Health Evidence
      Urology
      Audience(s)
      Health sciences
      Languages used
      English
      Key words
      Bladder cancer; Tumor stage; Tumor multiplicity; Aggressiveness; Smoking
      Abstract
      This data set is part of the Nijmegen Bladder Cancer Study, one of the largest series of bladder cancer in the world (see https://icbc.cancer.gov/). The data were used to investigate the relationship between smoking and bladder cancer aggressiveness at diagnosis. The results are published in Barbosa A.L.A. et al., Smoking intensity and bladder cancer aggressiveness at diagnosis. The Nijmegen Bladder Cancer Study (NBCS) has been described in more detail in (http://www.ncbi.nlm.nih.gov/pubmed/25023787). Briefly, BC patients diagnosed between 1995-2011 under the age of 75 years in the mid-eastern part of the Netherlands were identified through the Netherlands Cancer Registry (NCR) held by the Netherlands Comprehensive Cancer Organization (IKNL) and contacted via their treating physicians. Patients who consented to participate in the study were asked to fill out a lifestyle questionnaire, including questions on education, occupation, medical history, physical activity, and complete history of smoking. Furthermore, blood samples were collected by Thrombosis Service centers, which hold offices in all the communities in the region. The study was approved by the institutional review board of the Radboud university medical center, Nijmegen, The Netherlands (CMO Arnhem-Nijmegen). A total of 1859 BC patients were included in the study. Smoking assessment Information on smoking history was obtained via the lifestyle questionnaire. Patients were asked for their smoking status at recruitment, age at smoking initiation and cessation, number of cigarettes, pipes and cigars smoked per day and duration of smoking in years. The timing of smoking cessation with respect to the diagnosis was calculated as age at diagnosis minus age at cessation. Smoking status at diagnosis was classified as never smoker, former smoker (quitted >1 year before diagnosis), current smoker (continuing cigarette smoker or quitted ≤ 1 year before diagnosis). Ever smokers were defined as the combination of former and current smokers. In the current smokers group, only the smoking period in years before the diagnosis was considered. Smoking amount was evaluated as cigarettes per day. Cumulative smoking exposure (in pack-years) was calculated by multiplying the cigarette smoking duration and packages per day (20 cigarettes representing one package). Pipe and/or cigar smoking (5.9% of all patients) was ignored in the main analyses, assuming that the majority of Dutch pipe and cigar smokers do not inhale the smoke. Outcome assessment Detailed clinical data concerning age at diagnosis, tumor stage, tumor grade, tumor number (single or multiple), tumor size (<3cm and ≥ 3cm), presence of concomitant CIS, and histological type were collected through a medical file survey. Tumor stage and grade were recorded according to the final conclusion in the pathology report. Tumors with WHO 1973 differentiation grade 1 or 2, WHO/ISUP 2004 low grade, or Malmström (Modified Bergkvist) grade 1 or 2a were considered low-grade tumors. We classified tumors with WHO 1973 differentiation grade 3, WHO/ISUP 2004 high grade, or Malmström (Modified Bergkvist) grade 2b or 3 as high-grade. Tumor aggressiveness was classified according to the risk of progression as follows: low-risk NMIBC (low-grade Ta tumors), high-risk NMIBC (all stage T1 tumors, all high-grade tumors, or CIS) and MIBC (stage ≥ T2 or any stage with ≥N1 and/or M1 ). Statistical analysis Patient and tumor characteristics were compared between the smoking status categories using chi-square, Fisher exact, and one-way analysis of variance (ANOVA) tests where appropriate. The distribution of continuous smoking variables was compared between the categories of tumor multiplicity and tumor aggressiveness and tested for statistical significance using the non-parametric Kruskal-Wallis test. Multinomial logistic regression was used to analyze the relation between smoking intensity and aggressiveness of the tumor with adjustment for gender and age at diagnosis. Low-risk NMIBC was considered as the reference group. We repeated similar analyses for tumor multiplicity as the dependent variable using solitary tumors as the reference group. The association of each smoking intensity variable (smoking amount, smoking duration and cumulative smoking exposure), age at smoking initiation, and time since smoking cessation was assessed separately in ever, former and current smokers. Statistical analysis was performed using IBM SPSS Statistics for Windows 20 (IBCM Corp., Armonk, NY, USA) with a p value < 0.05 indicating statistical significance. This dataset contains the statistical datafile (SPSS) used for the data analyses, saved as a .sav and a .por.
      This item appears in the following Collection(s)
      • Datasets [1528]
      • Faculty of Medical Sciences [89033]
       
      •  Upload Full Text
      •  Terms of Use
      •  Notice and Takedown
      Bookmark and Share
      Admin login